Pimecrolimus and tacrolimus, 2 topical calcineurin inhibitors for the treatment of atopic dermatitis (AD), were not shown to increase the risk of cancer based on moderate-certainty evidence from a ...

Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Researchers showed with moderate certainty that topical calcineurin inhibitors did not ...

June 2, 2008 (Toronto) — A postoperative regimen that avoids long-term use of calcineurin inhibitors (CNIs) in renal transplant patients improves kidney function at 1 year, according to results of the ...

Getty Images Nephrotoxicity remains a major concern with the use of calcineurin inhibitors. Adding the calcineurin inhibitor tacrolimus to standard immunosuppression may further reduce proteinuria in ...

Tralokinumab plus optional use of TCS or TCI in adults with moderate to severe AD was associated with stable disease control for up to 4 years.

Dr Dunn leads a discussion outlining frontline therapies for the treatment of vitiligo. Jeffrey D. Dunn, PharmD, MBA: What therapies are being used? Are they generally covered by different books of ...

It is only very late in pregnancy that the lungs of the fetus complete their development so that the fetus will be able to breathe air when it is born. As a result, many premature babies suffer from ...